Cargando…
An Alteration of Lymphocytes Subpopulations and Immunoglobulins Levels in Patients with Diabetic Foot Ulcers Infected Particularly by Resistant Pathogens
The aim of our study was to analyse immune abnormalities in patients with chronic infected diabetic foot ulcers (DFUs) especially those infected by resistant microorganisms. Methods. 68 patients treated in our foot clinic for infected chronic DFUs with 34 matched diabetic controls were studied. Pati...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5165150/ https://www.ncbi.nlm.nih.gov/pubmed/28050566 http://dx.doi.org/10.1155/2016/2356870 |
_version_ | 1782482785973305344 |
---|---|
author | Fejfarová, Vladimíra Jirkovská, Alexandra Dubský, Michal Game, Frances Vydláková, Jana Sekerková, Alena Franeková, Jana Kučerová, Monika Stříž, Ilja Petkov, Vladimír Bém, Robert Wosková, Veronika Němcová, Andrea Skibová, Jelena |
author_facet | Fejfarová, Vladimíra Jirkovská, Alexandra Dubský, Michal Game, Frances Vydláková, Jana Sekerková, Alena Franeková, Jana Kučerová, Monika Stříž, Ilja Petkov, Vladimír Bém, Robert Wosková, Veronika Němcová, Andrea Skibová, Jelena |
author_sort | Fejfarová, Vladimíra |
collection | PubMed |
description | The aim of our study was to analyse immune abnormalities in patients with chronic infected diabetic foot ulcers (DFUs) especially those infected by resistant microorganisms. Methods. 68 patients treated in our foot clinic for infected chronic DFUs with 34 matched diabetic controls were studied. Patients with infected DFUs were subdivided into two subgroups according to the antibiotic sensitivity of causal pathogen: subgroup S infected by sensitive (n = 50) and subgroup R by resistant pathogens (n = 18). Selected immunological markers were compared between the study groups and subgroups. Results. Patients with infected chronic DFUs had, in comparison with diabetic controls, significantly reduced percentages (p < 0.01) and total numbers of lymphocytes (p < 0.001) involving B lymphocytes (p < 0.01), CD4+ (p < 0.01), and CD8+ T cells (p < 0.01) and their naive and memory effector cells. Higher levels of IgG (p < 0.05) including IgG1 (p < 0.001) and IgG3 (p < 0.05) were found in patients with DFUs compared to diabetic controls. Serum levels of immunoglobulin subclasses IgG2 and IgG3 correlated negatively with metabolic control (p < 0.05). A trend towards an increased frequency of IgG2 deficiency was found in patients with DFUs compared to diabetic controls (22% versus 15%; NS). Subgroup R revealed lower levels of immunoglobulins, especially of IgG4 (p < 0.01) in contrast to patients infected by sensitive bacteria. The innate immunity did not differ significantly between the study groups. Conclusion. Our study showed changes mainly in the adaptive immune system represented by low levels of lymphocyte subpopulations and their memory effector cells, and also changes in humoral immunity in patients with DFUs, even those infected by resistant pathogens, in comparison with diabetic controls. |
format | Online Article Text |
id | pubmed-5165150 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-51651502017-01-03 An Alteration of Lymphocytes Subpopulations and Immunoglobulins Levels in Patients with Diabetic Foot Ulcers Infected Particularly by Resistant Pathogens Fejfarová, Vladimíra Jirkovská, Alexandra Dubský, Michal Game, Frances Vydláková, Jana Sekerková, Alena Franeková, Jana Kučerová, Monika Stříž, Ilja Petkov, Vladimír Bém, Robert Wosková, Veronika Němcová, Andrea Skibová, Jelena J Diabetes Res Research Article The aim of our study was to analyse immune abnormalities in patients with chronic infected diabetic foot ulcers (DFUs) especially those infected by resistant microorganisms. Methods. 68 patients treated in our foot clinic for infected chronic DFUs with 34 matched diabetic controls were studied. Patients with infected DFUs were subdivided into two subgroups according to the antibiotic sensitivity of causal pathogen: subgroup S infected by sensitive (n = 50) and subgroup R by resistant pathogens (n = 18). Selected immunological markers were compared between the study groups and subgroups. Results. Patients with infected chronic DFUs had, in comparison with diabetic controls, significantly reduced percentages (p < 0.01) and total numbers of lymphocytes (p < 0.001) involving B lymphocytes (p < 0.01), CD4+ (p < 0.01), and CD8+ T cells (p < 0.01) and their naive and memory effector cells. Higher levels of IgG (p < 0.05) including IgG1 (p < 0.001) and IgG3 (p < 0.05) were found in patients with DFUs compared to diabetic controls. Serum levels of immunoglobulin subclasses IgG2 and IgG3 correlated negatively with metabolic control (p < 0.05). A trend towards an increased frequency of IgG2 deficiency was found in patients with DFUs compared to diabetic controls (22% versus 15%; NS). Subgroup R revealed lower levels of immunoglobulins, especially of IgG4 (p < 0.01) in contrast to patients infected by sensitive bacteria. The innate immunity did not differ significantly between the study groups. Conclusion. Our study showed changes mainly in the adaptive immune system represented by low levels of lymphocyte subpopulations and their memory effector cells, and also changes in humoral immunity in patients with DFUs, even those infected by resistant pathogens, in comparison with diabetic controls. Hindawi Publishing Corporation 2016 2016-12-05 /pmc/articles/PMC5165150/ /pubmed/28050566 http://dx.doi.org/10.1155/2016/2356870 Text en Copyright © 2016 Vladimíra Fejfarová et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Fejfarová, Vladimíra Jirkovská, Alexandra Dubský, Michal Game, Frances Vydláková, Jana Sekerková, Alena Franeková, Jana Kučerová, Monika Stříž, Ilja Petkov, Vladimír Bém, Robert Wosková, Veronika Němcová, Andrea Skibová, Jelena An Alteration of Lymphocytes Subpopulations and Immunoglobulins Levels in Patients with Diabetic Foot Ulcers Infected Particularly by Resistant Pathogens |
title | An Alteration of Lymphocytes Subpopulations and Immunoglobulins Levels in Patients with Diabetic Foot Ulcers Infected Particularly by Resistant Pathogens |
title_full | An Alteration of Lymphocytes Subpopulations and Immunoglobulins Levels in Patients with Diabetic Foot Ulcers Infected Particularly by Resistant Pathogens |
title_fullStr | An Alteration of Lymphocytes Subpopulations and Immunoglobulins Levels in Patients with Diabetic Foot Ulcers Infected Particularly by Resistant Pathogens |
title_full_unstemmed | An Alteration of Lymphocytes Subpopulations and Immunoglobulins Levels in Patients with Diabetic Foot Ulcers Infected Particularly by Resistant Pathogens |
title_short | An Alteration of Lymphocytes Subpopulations and Immunoglobulins Levels in Patients with Diabetic Foot Ulcers Infected Particularly by Resistant Pathogens |
title_sort | alteration of lymphocytes subpopulations and immunoglobulins levels in patients with diabetic foot ulcers infected particularly by resistant pathogens |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5165150/ https://www.ncbi.nlm.nih.gov/pubmed/28050566 http://dx.doi.org/10.1155/2016/2356870 |
work_keys_str_mv | AT fejfarovavladimira analterationoflymphocytessubpopulationsandimmunoglobulinslevelsinpatientswithdiabeticfootulcersinfectedparticularlybyresistantpathogens AT jirkovskaalexandra analterationoflymphocytessubpopulationsandimmunoglobulinslevelsinpatientswithdiabeticfootulcersinfectedparticularlybyresistantpathogens AT dubskymichal analterationoflymphocytessubpopulationsandimmunoglobulinslevelsinpatientswithdiabeticfootulcersinfectedparticularlybyresistantpathogens AT gamefrances analterationoflymphocytessubpopulationsandimmunoglobulinslevelsinpatientswithdiabeticfootulcersinfectedparticularlybyresistantpathogens AT vydlakovajana analterationoflymphocytessubpopulationsandimmunoglobulinslevelsinpatientswithdiabeticfootulcersinfectedparticularlybyresistantpathogens AT sekerkovaalena analterationoflymphocytessubpopulationsandimmunoglobulinslevelsinpatientswithdiabeticfootulcersinfectedparticularlybyresistantpathogens AT franekovajana analterationoflymphocytessubpopulationsandimmunoglobulinslevelsinpatientswithdiabeticfootulcersinfectedparticularlybyresistantpathogens AT kucerovamonika analterationoflymphocytessubpopulationsandimmunoglobulinslevelsinpatientswithdiabeticfootulcersinfectedparticularlybyresistantpathogens AT strizilja analterationoflymphocytessubpopulationsandimmunoglobulinslevelsinpatientswithdiabeticfootulcersinfectedparticularlybyresistantpathogens AT petkovvladimir analterationoflymphocytessubpopulationsandimmunoglobulinslevelsinpatientswithdiabeticfootulcersinfectedparticularlybyresistantpathogens AT bemrobert analterationoflymphocytessubpopulationsandimmunoglobulinslevelsinpatientswithdiabeticfootulcersinfectedparticularlybyresistantpathogens AT woskovaveronika analterationoflymphocytessubpopulationsandimmunoglobulinslevelsinpatientswithdiabeticfootulcersinfectedparticularlybyresistantpathogens AT nemcovaandrea analterationoflymphocytessubpopulationsandimmunoglobulinslevelsinpatientswithdiabeticfootulcersinfectedparticularlybyresistantpathogens AT skibovajelena analterationoflymphocytessubpopulationsandimmunoglobulinslevelsinpatientswithdiabeticfootulcersinfectedparticularlybyresistantpathogens AT fejfarovavladimira alterationoflymphocytessubpopulationsandimmunoglobulinslevelsinpatientswithdiabeticfootulcersinfectedparticularlybyresistantpathogens AT jirkovskaalexandra alterationoflymphocytessubpopulationsandimmunoglobulinslevelsinpatientswithdiabeticfootulcersinfectedparticularlybyresistantpathogens AT dubskymichal alterationoflymphocytessubpopulationsandimmunoglobulinslevelsinpatientswithdiabeticfootulcersinfectedparticularlybyresistantpathogens AT gamefrances alterationoflymphocytessubpopulationsandimmunoglobulinslevelsinpatientswithdiabeticfootulcersinfectedparticularlybyresistantpathogens AT vydlakovajana alterationoflymphocytessubpopulationsandimmunoglobulinslevelsinpatientswithdiabeticfootulcersinfectedparticularlybyresistantpathogens AT sekerkovaalena alterationoflymphocytessubpopulationsandimmunoglobulinslevelsinpatientswithdiabeticfootulcersinfectedparticularlybyresistantpathogens AT franekovajana alterationoflymphocytessubpopulationsandimmunoglobulinslevelsinpatientswithdiabeticfootulcersinfectedparticularlybyresistantpathogens AT kucerovamonika alterationoflymphocytessubpopulationsandimmunoglobulinslevelsinpatientswithdiabeticfootulcersinfectedparticularlybyresistantpathogens AT strizilja alterationoflymphocytessubpopulationsandimmunoglobulinslevelsinpatientswithdiabeticfootulcersinfectedparticularlybyresistantpathogens AT petkovvladimir alterationoflymphocytessubpopulationsandimmunoglobulinslevelsinpatientswithdiabeticfootulcersinfectedparticularlybyresistantpathogens AT bemrobert alterationoflymphocytessubpopulationsandimmunoglobulinslevelsinpatientswithdiabeticfootulcersinfectedparticularlybyresistantpathogens AT woskovaveronika alterationoflymphocytessubpopulationsandimmunoglobulinslevelsinpatientswithdiabeticfootulcersinfectedparticularlybyresistantpathogens AT nemcovaandrea alterationoflymphocytessubpopulationsandimmunoglobulinslevelsinpatientswithdiabeticfootulcersinfectedparticularlybyresistantpathogens AT skibovajelena alterationoflymphocytessubpopulationsandimmunoglobulinslevelsinpatientswithdiabeticfootulcersinfectedparticularlybyresistantpathogens |